HOME › DRUGS › SITAGLIPTIN, METFORMIN HYDROCHLORIDE
ACTIVE SUBSTANCE / INN

SITAGLIPTIN, METFORMIN HYDROCHLORIDE

Brand name(s): SITAGLIPTIN AND METFORMIN HCL, SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
FDA LISTED
NONE (TENTATIVE APPROVAL)
ANDA212869
ANDA218971
ACTIVE SUBSTANCE
Sitagliptin, Metformin Hydrochloride
REGULATORS
FDA
SPONSORS / MAH
MANKIND PHARMA LTD, SINOTHERAPEUTICS INC
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
SITAGLIPTIN AND METFORMIN HCLANDA218971MANKIND PHARMA LTDNone (Tentative Approval)
SITAGLIPTIN AND METFORMIN HYDROCHLORIDEANDA212869SINOTHERAPEUTICS INCNone (Tentative Approval)

FULL INTELLIGENCE ON SITAGLIPTIN, METFORMIN HYDROCHLORIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →